"Flutamide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antiandrogen with about the same potency as cyproterone in rodent and canine species.
| Descriptor ID |
D005485
|
| MeSH Number(s) |
D02.065.199.420 D02.092.146.113.420
|
| Concept/Terms |
Eulexin- Eulexin
- Euflex
- Drogenil
- Eulexine
|
Below are MeSH descriptors whose meaning is more general than "Flutamide".
Below are MeSH descriptors whose meaning is more specific than "Flutamide".
This graph shows the total number of publications written about "Flutamide" by people in this website by year, and whether "Flutamide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 1 | 2 |
| 1998 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Flutamide" by people in Profiles.
-
Cunha AAP, Partridge CG, Knapp R, Neff BD. Androgen and prolactin manipulation induces changes in aggressive and nurturing behavior in a fish with male parental care. Horm Behav. 2019 11; 116:104582.
-
Rodgers CM, Neff BD, Knapp R. Androgen-mediated nurturing and aggressive behaviors during paternal care in bluegill sunfish (Lepomis macrochirus). Horm Behav. 2013 Mar; 63(3):454-61.
-
Pitkänen-Arsiola T, Tillman JE, Gu G, Yuan J, Roberts RL, Wantroba M, Coetzee GA, Cookson MS, Kasper S. Androgen and anti-androgen treatment modulates androgen receptor activity and DJ-1 stability. Prostate. 2006 Aug 01; 66(11):1177-93.
-
Zimmerman RA, Culkin DJ. Clinical strategies in the management of biochemical recurrence after radical prostatectomy. Clin Prostate Cancer. 2003 Dec; 2(3):160-6.
-
Eisenberger MA, Blumenstein BA, Crawford ED, Miller G, McLeod DG, Loehrer PJ, Wilding G, Sears K, Culkin DJ, Thompson IM, Bueschen AJ, Lowe BA. Bilateral orchiectomy with or without flutamide for metastatic prostate cancer. N Engl J Med. 1998 Oct 08; 339(15):1036-42.
-
Fair WR, Cookson MS, Stroumbakis N, Cohen D, Aprikian AG, Wang Y, Russo P, Soloway SM, Sogani P, Sheinfeld J, Herr H, Dalgabni G, Begg CB, Heston WD, Reuter VE. The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results. Urology. 1997 Mar; 49(3A Suppl):46-55.
-
Cookson MS, Sogani PC, Russo P, Sheinfeld J, Herr H, Dalbagni G, Reuter VE, Begg CB, Fair WR. Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer: results of a phase II study. Br J Urol. 1997 Mar; 79(3):432-8.
-
Spicer LJ, Hammond JM. Comparative effects of androgens and catecholestrogens on progesterone production by porcine granulosa cells. Mol Cell Endocrinol. 1988 Apr; 56(3):211-7.